# Clinical Characteristics and Risk Factors for Chronic Pulmonary Aspergillosis in Patients with Nontuberculous Mycobacterial Pulmonary Disease

**Authors:** Ming Wang, Xia Yu, Hairong Huang, Hongfei Duan

PMC · DOI: 10.3390/jcm15041561 · 2026-02-16

## TL;DR

This study identifies risk factors for chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease and highlights the importance of early detection.

## Contribution

The study provides new insights into risk factors and clinical outcomes of CPA in NTM-PD patients in mainland China.

## Key findings

- 26.6% of NTM-PD patients had concurrent CPA.
- Male sex, dyspnea, and cavity were significant risk factors for CPA.
- Unadjusted mortality was higher in NTM-PD patients with CPA.

## Abstract

Background: The incidence of patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) complicated by chronic pulmonary aspergillosis (CPA) has been increasing. CPA is known to be associated with complex treatment regimens and a poor prognosis. However, data from mainland China remain scarce. This single-center retrospective study aimed to evaluate the clinical characteristics, risk factors, and prognoses of patients with concurrent CPA and NTM-PD. Methods: We conducted a retrospective review of the medical records of 248 patients diagnosed with NTM-PD. Risk factors for CPA were analyzed via multiple logistic regression, followed by survival analysis. Results: Among the 248 patients with NTM-PD, 66 (26.6%) were diagnosed with CPA. Independent risk factors for NTM-PD and CPA coinfection included male sex (OR 2.13, 95% CI: 1.03–4.47), dyspnea (OR 27.9, 95% CI: 4.24–570), cavity (OR 5.95, 95% CI: 2.76–13.9), use of oral corticosteroids (OR 4.28, 95% CI: 1.13–16.6), and interstitial lung disease (OR 15.5, 95% CI: 1.89–361). The wide confidence intervals for some risk factors reflect limited precision. The Kaplan–Meier survival curves indicated a significant divergence between the NTM-PD group and the NTM-PD with CPA group (log-rank test, p = 0.00039). However, the adjusted hazard ratio was not statistically significant (HR 2.01, 95% CI: 0.66–6.12, p = 0.217). Conclusions: In patients with NTM-PD, the presence of concurrent CPA was associated with higher unadjusted mortality. Clinicians should maintain a high index of suspicion for CPA to ensure prompt diagnosis and treatment, particularly in high-risk individuals.

## Linked entities

- **Diseases:** interstitial lung disease (MONDO:0015925)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** COPD (MESH:D029424), ILD (MESH:D017563), pulmonary fibrosis (MESH:D011658), hemoptysis (MESH:D006469), tuberculosis (MESH:D014376), chronic respiratory failure (MESH:D012131), CPA (MESH:D055744), MAC (MESH:D015270), fungal (MESH:D009181), Aspergillus infection (MESH:D001228), fever (MESH:D005334), Mortality (MESH:D003643), NTM- PD (MESH:D010300), traction bronchiectasis (MESH:D001987), MABC (MESH:D009165), respiratory infection (MESH:D012141), injury to (MESH:D014947), chronic pulmonary infections (MESH:D000088562), inflammation (MESH:D007249), fibrosis (MESH:D005355), cough (MESH:D003371), emphysema (MESH:D004646), pulmonary tuberculosis (MESH:D014397), NTM infection (MESH:D007239), Dyspnea (MESH:D004417), diabetes (MESH:D003920), NTM-PD (MESH:D008171), opportunistic infections (MESH:D009894)
- **Chemicals:** itraconazole (MESH:D017964), steroid (MESH:D013256), voriconazole (MESH:D065819), CPA (-), prednisolone (MESH:D011239)
- **Species:** Aspergillus (genus) [taxon 5052], Mycobacterium gordonae (species) [taxon 1778], Mycobacterium kansasii (species) [taxon 1768], Mycobacterium scrofulaceum (species) [taxon 1783], Mycobacteroides chelonae (species) [taxon 1774], Mycobacterium avium complex sp. (species) [taxon 37162], Homo sapiens (human, species) [taxon 9606], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mycobacterium xenopi (species) [taxon 1789]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942098/full.md

---
Source: https://tomesphere.com/paper/PMC12942098